Description
This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several others.
The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains 155 pages
Table of Contents
Current and Emerging Technologies
Molecular Diagnostics
- a. Technology Overview
- b. Amplification Methods
- Polymerase Chain Reaction
- Temperature Cyclers
- PCR Variations
- Immuno-PCR
- QC-PCR
- DAP-PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- Nucleic-Acid Sequence-Based
- Strand Displacement Activation
Monoclonal Antibodies
Immunoassays
- a. Technological Principle
- b. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Dot Immunobinding Assays
- Capillary Immunoassays
- Particle-Membrane Capture Immunoassays
- Enzyme Amplification
- c. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- d. Luminescence
- Chemiluminescence
- Bioluminescence
- e. Latex Agglutination
- f. Immunoprecipitation
- Differential Light Scattering
- IT
- Artificial Intelligence
- Liposomes
- Flow Cytometry
- Chromatography
- MRI
- Gel Microdroplets
- Other
Competitive Profiles
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako
CompetitiveWatch Infectious Disease Testing: Strategic Profiles of Leading Suppliers published by Venture Planning Group in May 14, 2013. This report price starts from US $ 3500.
The contents of this page may be different from the latest version. Please contact us for details.
